Is Ayala Pharmaceuticals, Inc. (ADXS) a Buy, Sell, or Hold?
OTC : ADXS
Ayala Pharmaceuticals, Inc.
$0.60355 USD
$0 (0.0%)
- Volume
- 10.01K
- Average Volume
- 5.05K
- Market Capitalization
- $25.71M
- P/E Ratio
- -0.08
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.80
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.30
Company Overview
OTC
Kenneth A. Berlin
Biotechnology
Healthcare
ADXS
20
US
USD
Liquidity Metrics
-0.34
0.30
0.30
0.20
0.00
Sales & Valuation
$13000
1977.51
-0.15
-0.87
-4.90
Profitability
-$7.99
-$48.07M
-369784.62%
-399876.92%
12170.13%
-289.96%
P/E Metrics
-0.08
0.00
0.00
Analyst Price Target & Rating
0/5
8 Analysts
%
Financial Health Scores
-24.78
1/9
-$17.49M
$16.58M
$41M
-$36.36M
Key Metrics (TTM)
$29.14M
2241.66
-0.81
0.30
12170.13%
405.38%
-1323.27%
-114.69%
-170595 days
Company Executives
| Name | Title |
|---|---|
| Dana Gelbaum | GM & Chief Business Officer |
| Irit Klipper Avni | Vice President of Human Resources |
| Kenneth A. Berlin | Chief Executive Officer, President & Director |
Poll Results
No votes yet today — be the first to share your view!
About Ayala Pharmaceuticals, Inc. (OTC:ADXS) Stock
Ayala Pharmaceuticals, Inc., a clinical-stage oncology firm, focuses on developing and commercializing small molecule therapies for individuals battling rare tumors and aggressive cancers. Its primary drug candidates currently in development include AL102, an oral gamma secretase inhibitor for desmoid tumors, and aspacytarabine (BST-236), an innovative, proprietary anti-metabolite designed for first-line treatment in acute myeloid leukemia patients who are considered unfit. The company is headquartered in Wilmington, Delaware. ...
Frequently Asked Questions
-
What is the current Ayala Pharmaceuticals, Inc. (ADXS) stock price?
-
Ayala Pharmaceuticals, Inc.(OTC:ADXS) stock price is $0.60355 in the last trading session. During the trading session, ADXS stock reached the peak price of $0.801 while $0.0011 was the lowest point it dropped to. The percentage change in ADXS stock occurred in the recent session was 0.0% while the dollar amount for the price change in ADXS stock was $0.
-
ADXS's industry and sector of operation?
-
The OTC listed ADXS is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of ADXS?
-
Dana Gelbaum | GM & Chief Business Officer
Irit Klipper Avni | Vice President of Human Resources
Kenneth A. Berlin | Chief Executive Officer, President & Director
|
| -
How many employees does ADXS have?
-
Number of ADXS employees currently stands at 20. ADXS operates from 9 Deer Park Drive, Monmouth Junction, NJ 08852, US.
-
Link for ADXS official website?
-
Official Website of ADXS is: https://www.ayalapharma.com
-
How do I contact ADXS?
-
ADXS could be contacted at phone #609 452 9813 and can also be accessed through its website. ADXS operates from 9 Deer Park Drive, Monmouth Junction, NJ 08852, US.
-
How many shares of ADXS are traded daily?
-
The average number of ADXS shares traded daily for last 3 months was 5.05K.
-
What is the market cap of ADXS currently?
-
The market value of ADXS currently stands at $25.71M with its latest stock price at $0.60355